Skip to main content
Clinical Trials/DRKS00016330
DRKS00016330CompletedPhase 3

Multicentre, randomized controlled trial of the Frankfurt Early Intervention Program for tod-dlers and preschool children with Autism Spectrum Disorder – A-FFIP - A-FFIP

Goethe Universität Frankfurt am Main0 sites134 target enrollmentStarted: January 4, 2019Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
134

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
24 Months to 66 Months (—)
Sex
All

Inclusion Criteria

  • Autism Spectrum Disorder according to DSM-5

Exclusion Criteria

  • Key exclusion criteria: non-verbal IQ/DQ <= 30, non-verbal mental age < =12 months, sensory impairments, cerebral palsy, chronic neurological disorder, unstable epilepsy, neurodegenerative disorder, Rett / Angelman Syndrome, severe psychosocial deprivation, insufficient care by parents, attachment disorder, institutional upbringing, parents not verbally fluent in German and/or unable to read German. Amendment from October 16, 2018: A correction of the key exclusion criteria from non-verbal IQ/DQ <40, non-verbal mental age < 15 months to non-verbal IQ/DQ <= 30, non-verbal mental age < =12 months was submitted. The ethics commission accepted this on January 24, 2019.

Investigators

Similar Trials

Multicentre, randomized controlled trial... | Clinical Trial